antiviral news

Press Releases in the global landscape

Mar 18, 2026

Antibiotic used in COVID patients tied to increased signs of antibiotic resistance

A study of hospitalized COVID patients finds use of azithromycin was associated with increased expression of antibiotic resistance genes in the upper airway after only one day of exposure.

Mar 16, 2026

Inappropriate antibiotic use for COVID-19 is linked to resistance

Researchers at UC San Francisco found that even brief azithromycin use in hospitalized COVID-19 patients can trigger antibiotic resistance in the respiratory tract microbiome, underscoring the risks of inappropriate antibiotic prescribing.

Mar 12, 2026

Preclinical data for MDL-001 indicates potential across multiple viral infections

Preclinical data suggests that MDL-001, an oral antiviral candidate, may have activity across multiple viral families, supporting its development as a potential broad-spectrum antiviral therapy.

Mar 11, 2026

CDC: Antiviral use low among older COVID outpatients, despite higher risk for severe disease

Only 16% to 38% of non-hospitalized US COVID-19 patients aged 65 years and older were given an antiviral prescription.

Mar 9, 2026

GlobalData report highlights Model Medicines antiviral MDL-001

A GlobalData report highlighted Model Medicines’ experimental antiviral candidate MDL-001, noting its potential role in future pandemic preparedness efforts. The analysis points to the drug’s possible value in responding to emerging infectious disease threats.

Mar 4, 2026

Bioxytran Announces Positive Dose Optimization Results and Advances Toward Phase 3 Registrational Trial for ProLectin-M

Company Initiates Regulatory Discussions with CDSCO; Plans 408-Patient Pivotal Study Targeting Standard-Risk Several Viral Infected Outpatients.